HemaCare Transitions to the Spectra Optia Apheresis System
HemaCare is in the process of transitioning to the Spectra Optia® Apheresis System. This is an excellent alternative that allows a wide variety of apheresis procedures on a single platform, while providing superior cell collection efficiency and product purity. The transition will be seamless, and we will continue to use the COBE® Spectra Apheresis System as long as Terumo supports the platform. Not to worry, you will continue receiving the same outstanding quality that you expect from HemaCare.
Have questions? Please reach out to us to talk to an expert on our transition at 877-944-4362.